These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9920903)

  • 1. Regulation of the c-met proto-oncogene promoter by p53.
    Seol DW; Chen Q; Smith ML; Zarnegar R
    J Biol Chem; 1999 Feb; 274(6):3565-72. PubMed ID: 9920903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of the IKKalpha promoter: positive and negative regulation by ETS-1 and p53, respectively.
    Gu L; Zhu N; Findley HW; Woods WG; Zhou M
    J Biol Chem; 2004 Dec; 279(50):52141-9. PubMed ID: 15469934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein.
    Koutsodontis G; Tentes I; Papakosta P; Moustakas A; Kardassis D
    J Biol Chem; 2001 Aug; 276(31):29116-25. PubMed ID: 11384995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the p53 homolog p73 by adenoviral oncogene E1A.
    Das S; El-Deiry WS; Somasundaram K
    J Biol Chem; 2003 May; 278(20):18313-20. PubMed ID: 12639967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1.
    Seol DW; Chen Q; Zarnegar R
    Oncogene; 2000 Feb; 19(9):1132-7. PubMed ID: 10713700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function.
    Kong XT; Gao H; Stanbridge EJ
    J Biol Chem; 2001 Aug; 276(35):32990-3000. PubMed ID: 11395510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.
    Zacharatos PV; Gorgoulis VG; Kotsinas A; Manolis EN; Liloglou T; Rassidakis AN; Kanavaros P; Field JD; Halazonetis T; Kittas C
    Anticancer Res; 1999; 19(1A):579-87. PubMed ID: 10226602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.
    Miyashita T; Reed JC
    Cell; 1995 Jan; 80(2):293-9. PubMed ID: 7834749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrogation of p53 function affects gadd gene responses to DNA base-damaging agents and starvation.
    Zhan Q; Fan S; Smith ML; Bae I; Yu K; Alamo I; O'Connor PM; Fornace AJ
    DNA Cell Biol; 1996 Oct; 15(10):805-15. PubMed ID: 8892753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T-cell leukemia virus type 1 Tax activates cyclin-dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53-independent mechanism: Inhibition of cdk2.
    Chowdhury IH; Farhadi A; Wang XF; Robb ML; Birx DL; Kim JH
    Int J Cancer; 2003 Nov; 107(4):603-11. PubMed ID: 14520699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene.
    Schäfer H; Trauzold A; Sebens T; Deppert W; Fölsch UR; Schmidt WE
    Oncogene; 1998 May; 16(19):2479-87. PubMed ID: 9627114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53.
    Ori A; Zauberman A; Doitsh G; Paran N; Oren M; Shaul Y
    EMBO J; 1998 Jan; 17(2):544-53. PubMed ID: 9430645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional characterization of the mouse c-met proto-oncogene (hepatocyte growth factor receptor) promoter.
    Seol DW; Zarnegar R
    Biochim Biophys Acta; 1998 Feb; 1395(3):252-8. PubMed ID: 9512656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines.
    Bae I; Smith ML; Sheikh MS; Zhan Q; Scudiero DA; Friend SH; O'Connor PM; Fornace AJ
    Cancer Res; 1996 Feb; 56(4):840-7. PubMed ID: 8631022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter.
    Zhang W; Geiman DE; Shields JM; Dang DT; Mahatan CS; Kaestner KH; Biggs JR; Kraft AS; Yang VW
    J Biol Chem; 2000 Jun; 275(24):18391-8. PubMed ID: 10749849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cells.
    Wu Q; Kirschmeier P; Hockenberry T; Yang TY; Brassard DL; Wang L; McClanahan T; Black S; Rizzi G; Musco ML; Mirza A; Liu S
    J Biol Chem; 2002 Sep; 277(39):36329-37. PubMed ID: 12138103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor.
    Saramäki A; Banwell CM; Campbell MJ; Carlberg C
    Nucleic Acids Res; 2006; 34(2):543-54. PubMed ID: 16434701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a DNA element that can enhance p53-mediated transactivation.
    Shiio Y; Yamamoto T; Yamaguchi N
    Oncogene; 1993 Aug; 8(8):2059-65. PubMed ID: 8393159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.